TALS

Talaris Therapeutics Stock Price

14.80
0.16 (1.09%)
14.80

Low
11.39

52 Week Range

High
19.82

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Talaris Therapeutics Inc TALS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.16 1.09% 14.80 18:00:01
Open Price Low Price High Price Close Price Prev Close
14.93 13.865 15.25 14.80 14.64
Bid Price Ask Price Spread News
12.70 15.15 2.45 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,048 40,587 $ 14.63 $ 593,865 - 11.39 - 19.82
Last Trade Time Type Quantity Stock Price Currency
16:00:31 formt 202 $ 14.80 USD

Period:

Draw Mode:

Talaris Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 611.92M 41.35M 25.20M $ - $ - -1.07 -7.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 14.30%

more financials information »

Talaris Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TALS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.2715.3112.8314.0842,3341.5311.53%
1 Month12.5015.797211.3913.2637,2222.3018.4%
3 Months14.6915.797211.3913.5040,0010.110.75%
6 Months17.2519.8211.3914.61125,336-2.45-14.2%
1 Year17.2519.8211.3914.61125,336-2.45-14.2%
3 Years17.2519.8211.3914.61125,336-2.45-14.2%
5 Years17.2519.8211.3914.61125,336-2.45-14.2%

Talaris Therapeutics Description

Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.


Your Recent History
NASDAQ
TALS
Talaris Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.